Cargando…
The therapeutic efficacy of water-soluble coenzyme Q10 in an experimental model of tacrolimus-induced diabetes mellitus
BACKGROUND/AIMS: Coenzyme Q(10) (CoQ(10)) has antioxidant effects and is commercially available and marketed extensively. However, due to its low bioavailability, its effects are still controversial. We developed a water-soluble CoQ(10)-based micelle formulation (CoQ(10)-W) and tested it in an exper...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association of Internal Medicine
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7652663/ https://www.ncbi.nlm.nih.gov/pubmed/32279476 http://dx.doi.org/10.3904/kjim.2019.269 |
_version_ | 1783607737330958336 |
---|---|
author | Quan, Yi Luo, Kang Cui, Sheng Lim, Sun Woo Shin, Yoo Jin Ko, Eun Jeong Kim, Ju Hwan Chung, Sang J. Bae, Soo Kyung Chung, Byung Ha Yang, Chul Woo |
author_facet | Quan, Yi Luo, Kang Cui, Sheng Lim, Sun Woo Shin, Yoo Jin Ko, Eun Jeong Kim, Ju Hwan Chung, Sang J. Bae, Soo Kyung Chung, Byung Ha Yang, Chul Woo |
author_sort | Quan, Yi |
collection | PubMed |
description | BACKGROUND/AIMS: Coenzyme Q(10) (CoQ(10)) has antioxidant effects and is commercially available and marketed extensively. However, due to its low bioavailability, its effects are still controversial. We developed a water-soluble CoQ(10)-based micelle formulation (CoQ(10)-W) and tested it in an experimental model of tacrolimus (TAC)-induced diabetes mellitus (DM). METHODS: We developed CoQ(10)-W from a glycyrrhizic-carnitine mixed layer CoQ(10) micelle preparation based on acyltransferases. TAC-induced DM rats were treated with either lipid-soluble CoQ(10) (CoQ(10)-L) or CoQ(10)-W for 4 weeks. Their plasma and pancreatic CoQ(10) concentrations were measured using liquid chromatography- tandem mass spectrometry. The therapeutic efficacies of CoQ(10)-W and CoQ(10)-L on TAC-induced DM were compared using functional and morphological parameters and their effects on cell viability and reactive oxygen species (ROS) production were also evaluated in cultured rat insulinoma cells. RESULTS: The plasma CoQ(10) level was significantly increased in the CoQ(10)-W group compared to that in the CoQ(10)-L group. Intraperitoneal glucose tolerance tests and glucose-stimulated insulin secretion revealed that CoQ(10)-W controlled hyperglycemia and restored insulin secretion significantly better than CoQ(10)-L. The TAC-mediated decrease in pancreatic islet size was significantly attenuated by CoQ(10)-W but not by CoQ(10)-L. TAC-induced oxidative stress and apoptosis were significantly more reduced by CoQ(10)-W than CoQ(10)-L. Electron microscopy revealed that CoQ(10)-W restored TAC-induced attenuation in the number of insulin granules and the average mitochondrial area, unlike CoQ(10)-L. In vitro studies showed that CoQ(10)-L and CoQ(10)-W both improved cell viability and reduced ROS production in TAC-treated islet cells to a similar extent. CONCLUSIONS: CoQ(10)-W has better therapeutic efficacy than CoQ(10)-L in TAC-induced DM. |
format | Online Article Text |
id | pubmed-7652663 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | The Korean Association of Internal Medicine |
record_format | MEDLINE/PubMed |
spelling | pubmed-76526632020-11-18 The therapeutic efficacy of water-soluble coenzyme Q10 in an experimental model of tacrolimus-induced diabetes mellitus Quan, Yi Luo, Kang Cui, Sheng Lim, Sun Woo Shin, Yoo Jin Ko, Eun Jeong Kim, Ju Hwan Chung, Sang J. Bae, Soo Kyung Chung, Byung Ha Yang, Chul Woo Korean J Intern Med Original Article BACKGROUND/AIMS: Coenzyme Q(10) (CoQ(10)) has antioxidant effects and is commercially available and marketed extensively. However, due to its low bioavailability, its effects are still controversial. We developed a water-soluble CoQ(10)-based micelle formulation (CoQ(10)-W) and tested it in an experimental model of tacrolimus (TAC)-induced diabetes mellitus (DM). METHODS: We developed CoQ(10)-W from a glycyrrhizic-carnitine mixed layer CoQ(10) micelle preparation based on acyltransferases. TAC-induced DM rats were treated with either lipid-soluble CoQ(10) (CoQ(10)-L) or CoQ(10)-W for 4 weeks. Their plasma and pancreatic CoQ(10) concentrations were measured using liquid chromatography- tandem mass spectrometry. The therapeutic efficacies of CoQ(10)-W and CoQ(10)-L on TAC-induced DM were compared using functional and morphological parameters and their effects on cell viability and reactive oxygen species (ROS) production were also evaluated in cultured rat insulinoma cells. RESULTS: The plasma CoQ(10) level was significantly increased in the CoQ(10)-W group compared to that in the CoQ(10)-L group. Intraperitoneal glucose tolerance tests and glucose-stimulated insulin secretion revealed that CoQ(10)-W controlled hyperglycemia and restored insulin secretion significantly better than CoQ(10)-L. The TAC-mediated decrease in pancreatic islet size was significantly attenuated by CoQ(10)-W but not by CoQ(10)-L. TAC-induced oxidative stress and apoptosis were significantly more reduced by CoQ(10)-W than CoQ(10)-L. Electron microscopy revealed that CoQ(10)-W restored TAC-induced attenuation in the number of insulin granules and the average mitochondrial area, unlike CoQ(10)-L. In vitro studies showed that CoQ(10)-L and CoQ(10)-W both improved cell viability and reduced ROS production in TAC-treated islet cells to a similar extent. CONCLUSIONS: CoQ(10)-W has better therapeutic efficacy than CoQ(10)-L in TAC-induced DM. The Korean Association of Internal Medicine 2020-11 2020-04-14 /pmc/articles/PMC7652663/ /pubmed/32279476 http://dx.doi.org/10.3904/kjim.2019.269 Text en Copyright © 2020 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Quan, Yi Luo, Kang Cui, Sheng Lim, Sun Woo Shin, Yoo Jin Ko, Eun Jeong Kim, Ju Hwan Chung, Sang J. Bae, Soo Kyung Chung, Byung Ha Yang, Chul Woo The therapeutic efficacy of water-soluble coenzyme Q10 in an experimental model of tacrolimus-induced diabetes mellitus |
title | The therapeutic efficacy of water-soluble coenzyme Q10 in an experimental model of tacrolimus-induced diabetes mellitus |
title_full | The therapeutic efficacy of water-soluble coenzyme Q10 in an experimental model of tacrolimus-induced diabetes mellitus |
title_fullStr | The therapeutic efficacy of water-soluble coenzyme Q10 in an experimental model of tacrolimus-induced diabetes mellitus |
title_full_unstemmed | The therapeutic efficacy of water-soluble coenzyme Q10 in an experimental model of tacrolimus-induced diabetes mellitus |
title_short | The therapeutic efficacy of water-soluble coenzyme Q10 in an experimental model of tacrolimus-induced diabetes mellitus |
title_sort | therapeutic efficacy of water-soluble coenzyme q10 in an experimental model of tacrolimus-induced diabetes mellitus |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7652663/ https://www.ncbi.nlm.nih.gov/pubmed/32279476 http://dx.doi.org/10.3904/kjim.2019.269 |
work_keys_str_mv | AT quanyi thetherapeuticefficacyofwatersolublecoenzymeq10inanexperimentalmodeloftacrolimusinduceddiabetesmellitus AT luokang thetherapeuticefficacyofwatersolublecoenzymeq10inanexperimentalmodeloftacrolimusinduceddiabetesmellitus AT cuisheng thetherapeuticefficacyofwatersolublecoenzymeq10inanexperimentalmodeloftacrolimusinduceddiabetesmellitus AT limsunwoo thetherapeuticefficacyofwatersolublecoenzymeq10inanexperimentalmodeloftacrolimusinduceddiabetesmellitus AT shinyoojin thetherapeuticefficacyofwatersolublecoenzymeq10inanexperimentalmodeloftacrolimusinduceddiabetesmellitus AT koeunjeong thetherapeuticefficacyofwatersolublecoenzymeq10inanexperimentalmodeloftacrolimusinduceddiabetesmellitus AT kimjuhwan thetherapeuticefficacyofwatersolublecoenzymeq10inanexperimentalmodeloftacrolimusinduceddiabetesmellitus AT chungsangj thetherapeuticefficacyofwatersolublecoenzymeq10inanexperimentalmodeloftacrolimusinduceddiabetesmellitus AT baesookyung thetherapeuticefficacyofwatersolublecoenzymeq10inanexperimentalmodeloftacrolimusinduceddiabetesmellitus AT chungbyungha thetherapeuticefficacyofwatersolublecoenzymeq10inanexperimentalmodeloftacrolimusinduceddiabetesmellitus AT yangchulwoo thetherapeuticefficacyofwatersolublecoenzymeq10inanexperimentalmodeloftacrolimusinduceddiabetesmellitus AT quanyi therapeuticefficacyofwatersolublecoenzymeq10inanexperimentalmodeloftacrolimusinduceddiabetesmellitus AT luokang therapeuticefficacyofwatersolublecoenzymeq10inanexperimentalmodeloftacrolimusinduceddiabetesmellitus AT cuisheng therapeuticefficacyofwatersolublecoenzymeq10inanexperimentalmodeloftacrolimusinduceddiabetesmellitus AT limsunwoo therapeuticefficacyofwatersolublecoenzymeq10inanexperimentalmodeloftacrolimusinduceddiabetesmellitus AT shinyoojin therapeuticefficacyofwatersolublecoenzymeq10inanexperimentalmodeloftacrolimusinduceddiabetesmellitus AT koeunjeong therapeuticefficacyofwatersolublecoenzymeq10inanexperimentalmodeloftacrolimusinduceddiabetesmellitus AT kimjuhwan therapeuticefficacyofwatersolublecoenzymeq10inanexperimentalmodeloftacrolimusinduceddiabetesmellitus AT chungsangj therapeuticefficacyofwatersolublecoenzymeq10inanexperimentalmodeloftacrolimusinduceddiabetesmellitus AT baesookyung therapeuticefficacyofwatersolublecoenzymeq10inanexperimentalmodeloftacrolimusinduceddiabetesmellitus AT chungbyungha therapeuticefficacyofwatersolublecoenzymeq10inanexperimentalmodeloftacrolimusinduceddiabetesmellitus AT yangchulwoo therapeuticefficacyofwatersolublecoenzymeq10inanexperimentalmodeloftacrolimusinduceddiabetesmellitus |